| What if a 'Trojan horse' strategy could help address antimicrobial resistance? |
|---|
| Antimicrobial-resistant infections are predicted to become the second biggest cause of death worldwide by 2050. Despite increasing investment in the development of new antimicrobials, awareness campaigns on antimicrobial misuse and abuse, and monitoring of antimicrobial use and resistance in animals, humans and the environment, antimicrobial resistance continues to grow and the last three decades have not seen even one novel antimicrobial class reach the market. Could the answer lie in a 'Trojan horse' strategy to disrupt a natural physiological process common to all bacteria? |
Antimicrobial-resistant infections are predicted to become the second biggest cause of death worldwide by 2050. Despite increasing investment in the development of new antimicrobials, awareness campaigns on antimicrobial misuse and abuse, and monitoring of antimicrobial use and resistance in animals, humans and the environment, antimicrobial resistance continues to grow and the last three decades have not seen even one novel antimicrobial class reach the market. Could the answer lie in a 'Trojan horse' strategy to disrupt a natural physiological process common to all bacteria?
|
- Publication type:
- policy brief
- Publication language:
- English
- Publication date:
- 2022-11
- Publication URL:
- https://www.europarl.europa.eu/RegData/etudes/ATAG/2022/729544/EPRS_ATA(2022)729544_EN.pdf
- Institute:
- European Parliament / Panel for the Future of Science and Technology (STOA) (STOA)
- Country:
- EU
